Literature DB >> 9158881

Distribution of antihistamines into the CSF following intranasal delivery.

K J Chou1, M D Donovan.   

Abstract

The preferential absorption of certain drug compounds from the nasal cavity into the cerebrospinal fluid (CSF) raises questions regarding the transport processes controlling drug disposition following intranasal delivery. The disposition characteristics of several structurally similar antihistamine compounds, hydroxyzine, chlorpheniramine, triprolidine, and chlorcyclizine, into the CSF following nasal administration were studied using the rat as an animal model. The antihistamines were administered either intranasally or intra-arterially, and serial CSF and plasma samples were collected from the cisterna magna and the femoral artery, respectively. The drug levels in CSF and plasma were assayed by HPLC. Hydroxyzine concentrations in plasma and CSF were found to be significantly greater than most of the other compounds tested. In addition, hydroxyzine also showed the most rapid systemic absorption following nasal administration. Interestingly, the hydroxyzine levels in CSF following intranasal administration were significantly higher than those following intra-arterial administration. The AUC ratios between CSF and plasma for hydroxyzine after intranasal and intra-arterial administration were 4.0 and 0.4, respectively. The AUC ratios for triprolidine, the other antihistamine with measurable CSF concentrations, were 0.5 and 0.7, respectively. The distribution of antihistamines from the nasal membrane into the CSF appears to be controlled by a combination of their molecular properties. It also appears that the intranasal delivery of drugs with optimal physicochemical characteristics can result in an improved CNS bioavailability compared to those achieved from an equivalent parenteral dose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158881     DOI: 10.1002/(sici)1099-081x(199705)18:4<335::aid-bdd22>3.0.co;2-w

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  6 in total

1.  Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide.

Authors:  O Lardinois; P J Kirby; D L Morgan; R C Sills; K B Tomer; L J Deterding
Journal:  Rapid Commun Mass Spectrom       Date:  2014-12-15       Impact factor: 2.419

2.  Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.

Authors:  H D Kao; A Traboulsi; S Itoh; L Dittert; A Hussain
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

3.  Correlation between nasal membrane permeability and nasal absorption rate.

Authors:  Hefei Zhang; Chih-Wei Lin; Maureen D Donovan
Journal:  AAPS PharmSciTech       Date:  2012-12-07       Impact factor: 3.246

4.  Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Authors:  Manar Al-Ghabeish; Todd Scheetz; Mahfoud Assem; Maureen D Donovan
Journal:  Mol Pharm       Date:  2015-07-10       Impact factor: 4.939

5.  Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae.

Authors:  Karunya K Kandimalla; Maureen D Donovan
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

6.  Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.

Authors:  Mascha P van den Berg; Paul Merkus; Stefan G Romeijn; J Coos Verhoef; Frans W H M Merkus
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.